<DOC>
	<DOCNO>NCT01303887</DOCNO>
	<brief_summary>The purpose study determine whether R-FC beneficial R-CVP treatment old patient ( age 60 ) Follicular Lymphoma ( FL ) .</brief_summary>
	<brief_title>A Trial Looking Rituximab Chemotherapy Treatment Follicular Lymphoma Elderly Patients</brief_title>
	<detailed_description>FL predominantly affect elderly , yet optimum treatment old patient disease define . The present study aim address question compare drug combination currently consider gold-standard ( R-CVP ) new combination ( R-FC ) might effective without significantly toxic . In order take account balance efficacy toxicity , dual primary endpoint employ : progression-free survival toxicity form grade 3-4 infection .</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Lymphoma , Follicular</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Fludarabine phosphate</mesh_term>
	<mesh_term>Rituximab</mesh_term>
	<mesh_term>Fludarabine</mesh_term>
	<mesh_term>Vincristine</mesh_term>
	<mesh_term>Prednisolone</mesh_term>
	<mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
	<mesh_term>Prednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone</mesh_term>
	<mesh_term>Prednisolone hemisuccinate</mesh_term>
	<mesh_term>Prednisolone phosphate</mesh_term>
	<criteria>Histologically confirm follicular lymphoma ( grade 1,2 , 3a material available central review ) Ann Arbor stage IIIV Aged 60 year , age less 60 anthracyclinebased therapy contraindicate No prior systemic therapy ( one episode prior local radiotherapy allow ) At least one follow criterion initiation treatment : Rapid generalized disease progression precede 3 month Life threaten organ involvement Renal macroscopic liver infiltration Bone lesion Presence systemic symptom pruritus Haemoglobin &lt; 10 g/dL WBC &lt; 3.0 × 109/L platelet count &lt; 100 × 109/L due marrow involvement Adequate haematological function ( unless abnormality relate lymphoma infiltration bone marrow ) : Haemoglobin ≥ 8.0 g/dL Absolute neutrophil count ( ANC ) ≥ 1.5 x 109/L Platelet count ≥ 100 x 109/L Written Informed Consent Overt transformation diffuse large Bcell lymphoma Grade 3b follicular lymphoma Presence history CNS disease ( either CNS lymphoma lymphomatous meningitis ) WHO performance status 3 4 Impaired renal function define estimate Glomerular filtration rate ( eGFR ) &lt; 30 mL/min use Modification Diet Renal Disease ( MDRD ) formula Impaired hepatic function define serum bilirubin twice upper limit normal ( unless due lymphoma Gilbert 's syndrome ) Life expectancy le 12 month Preexisting neuropathy Active autoimmune haemolytic anaemia Serological evidence infection HIV , hepatitis B ( positivity surface antigen core antibody ) hepatitis C Allergy murine proteins Corticosteroid treatment last 4 week , unless administer dose equivalent prednisolone 20mg/day continuously single course prednisolone 1 mg/kg 7 day Concomitant malignancy except adequately treat localised nonmelanoma skin cancer adequately treat situ cervical cancer , cancer remission least 5 year follow surgery curative intent . Major surgery ( exclude lymph node biopsy ) within 28 day prior randomisation Serious underlie medical condition , could impair ability patient participate trial ( e.g . ongoing infection , uncontrolled diabetes mellitus , gastric ulcer , active autoimmune disease ) Treatment within clinical trial within 30 day prior trial entry Any coexist medical psychological condition preclude participation study compromise ability give inform consent Adult patient tutelage ( competent sign inform consent ) Pregnant lactate woman All men woman reproductive potential , unless use least two contraceptive precaution , one must condom</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2010</verification_date>
	<keyword>PACIFICO</keyword>
	<keyword>Follicular Lymphoma</keyword>
	<keyword>Non-Hodgkin 's Lymphoma</keyword>
	<keyword>Rituximab</keyword>
	<keyword>R-CVP</keyword>
	<keyword>R-FC</keyword>
	<keyword>Older</keyword>
</DOC>